000			03500nam a22003735i 4500
001			82321
003			ES-MaUEC
005			20230207040406.0
007			cr nn 008mamaa
008			150515s2015 gw | s |||| 0|eng d
020			_a9783319156033
024	7		_a10.1007/978-3-319-15603-3 _2doi
050		4	_aRC685.H8 _b2015 EB
245	1	0	_aAssessment of Preclinical Organ Damage in Hypertension _cedited by Enrico Agabiti Rosei, Giuseppe Mancia.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (VIII, 218 páginas) _b44 ilustraciones, 28 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aPART I: HEART 1 Electrocardiography -- 2 Echocardiography -- 3 New techniques: 3D, CT, MRI -- PART II: LARGE ARTERIES 4 Ultrasound of Carotid IMT and plaque.-Â{u5815}ltrasound of the Aorta/coronary arteries.-Â{u6810}ulse wave velocityÂ{u1BA4} central BP.-Â{u7801}nkle-brachial index -- 8 Atherosclerosis and general principles of arterial imaging -- 9 Imaging and ageing of the aorta and large arteries in the lower extremities -- PART III: SMALL ARTERIES 10 Micro myography -- 11 Damage of the retinal arterioles -- 12 Capillaroscopy -- 13 Other techniques for assessment -- PART IV: KIDNEY 14 Proteinuria -- 15 Glomerular Filtration Rate -- 16 Other techniques -- PART V: BRAIN 17 RMN/TC: Evaluation of Brain damage -- 18 Questionnaires for cognitive function -- 19 Other techniques for neurological damage.-Â{u2C20}Relation between blood pressure and markers of organ damage.
520	3		_aThis book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney in the general and the hypertensive population, using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		0	_9156795 _aPromoción de la salud
650		7	_aAngiología _2embne _9146287
650		7	_aNefrología _2embne _9143254
700	1		_aAgabiti Rosei, Enrico _eeditor literario _995170 _0Local
700	1		_aMancia, Giuseppe _eeditor literario _932248 _0comprobar BNE20022064899
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-15603-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12909610 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC685.H8 A874 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11577290 _z06-04-17
999			_c82321 _d82321 _x1